$256 million U.S. market opportunity drives expansion as company kicks off multi-channel promotional campaign Scienture Holdings (SCNX) announced the official...
REQORSA® gene therapy shows promise against hard-to-treat ALK-positive non-small cell lung cancer Clinical-stage gene therapy developer Genprex (GNPX) announced that...
Semiconductor optimism drives bullish calls on AMD and Monolithic Power while managed care stocks come under pressure Wall Street analysts...
Prospective acquisition of Protagonist Therapeutics centers on oral drug for immune diseases Johnson & Johnson (JNJ) is reportedly in active...
Positive early results accelerate timeline and reduce capital needs by up to $15 million Envoy Medical (COCH), a Minnesota-based hearing...
Exemptions for U.S. plant construction and existing expansion plans temper immediate fallout, but uncertainty remains for smaller firms Shares of...
Telehealth company maintains 2025 outlook, expands beyond GLP-1 offerings amid regulatory and partnership setbacks Hims & Hers Health (HIMS) stock...
PMN310 aims to deliver a safer, next-generation treatment by targeting toxic amyloid-beta in early-stage Alzheimer’s patients Shares of ProMIS Neurosciences...
Following a 38-to-1 stock split and explosive rally, the biotech firm's volatile trading persists despite a multi-year loss streak Regencell...
$710 Million Raised as David Bailey Leads Ambitious Plan to Transform Bitcoin Adoption Through Public Equity In a landmark move...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?